Molecular characterization of high-risk human papillomavirus (HR-HPV) in women in Lomé, Togo

被引：0
|
作者：
Akouélé P. Kuassi-Kpede
Essolakina Dolou
Théodora M. Zohoncon
Ina Marie Angèle Traore
Gnatoulma Katawa
R. Alice Ouedraogo
Esther Mah Traore
Prosper Bado
T. Clarisse Ouedraogo
Florencia Wendkuuni Djigma
Simplice Damintoti Karou
Jacques Simpore
机构：
[1] University JOSEPH KI-ZERBO,Molecular Biology and Genetics Laboratory (LABIOGENE), Department of Biochemistry and Microbiology
[2] Pietro Annigoni Biomolecular Research Centre (CERBA),Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA
[3] University of Lomé,UL)
来源：
BMC Infectious Diseases | / 21卷
关键词：
HR-HPV; Genotypes; PCR; Lomé; Togo;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The high-risk human papillomavirus (HR-HPV) infection: Do we know enough about its harbouring in the male urogenital tract?
    Smelov, V.
    Pleijster, J.
    Ouburg, S.
    Smelova, N.
    Van, Moorselaar R. J. A.
    Gorelov, A.
    Bemelmans, B. L. H.
    Savicheva, A.
    Morre, S. A.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 156 - 156
  • [22] Sensitivity of In-Situ Hybridization (ISH) for High-Risk Human Papillomavirus (HR-HPV) in Head & Neck Squamous Cell Carcinoma (HNSCC)
    Stevens, T. M.
    Dunn, S. T.
    Caughron, S.
    Gatalica, Z.
    [J]. MODERN PATHOLOGY, 2010, 23 : 437A - 438A
  • [23] Sensitivity of In-Situ Hybridization (ISH) for High-Risk Human Papillomavirus (HR-HPV) in Head & Neck Squamous Cell Carcinoma (HNSCC)
    Stevens, T. M.
    Dunn, S. T.
    Caughron, S.
    Gatalica, Z.
    [J]. LABORATORY INVESTIGATION, 2010, 90 : 437A - 438A
  • [24] Folate is associated with the acquisition, persistence and clearance of high-risk (HR) human papillomavirus (HPV)
    Piyathilake, CJ
    Henao, OL
    Meleth, S
    Partridge, E
    Heimburger, D
    [J]. FASEB JOURNAL, 2003, 17 (04): : A373 - A373
  • [25] High-Risk Human Papillomavirus (HR-HPV) DNA Detection in Mouthwashes for Diagnosis of HPV-Driven Oropharynx Cancer and Its Curative Therapy-A Feasibility Study
    Loermann, Gera
    Kolb, Marlen
    Prascevic, Dusan
    Siemert, Julia
    Wiegand, Susanne
    Zebralla, Veit
    Pirlich, Markus
    Stohr, Matthaus
    Dietz, Andreas
    Wald, Theresa
    Wichmann, Gunnar
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [26] The development of quality control panels for the high-risk human papilomavirus (HR-HPV) detection system.
    Wang, H.
    Mal, C.
    Zhou, Y.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [27] HIGH-RISK HUMAN PAPILLOMAVIRUS (HPV) INFECTION IN WOMEN UNDERGOING IN VITRO FERTILIZATION
    Jancar, Nina
    Bokal, Eda Vrtacnik
    Poljak, Mario
    Ostrbenk, Anja
    [J]. ZDRAVSTVENO VARSTVO, 2013, 52 (03): : 157 - 161
  • [28] A simple and rapid diagnostic method for 13 types of high-risk human papillomavirus (HR-HPV) detection using CRISPR-Cas12a technology
    Jiaojiao Gong
    Guanghui Zhang
    Wangguo Wang
    Liping Liang
    Qianyun Li
    Menghao Liu
    Liang Xue
    Guanghui Tang
    [J]. Scientific Reports, 11
  • [29] High-risk human papillomavirus (HPV) in parotid lesions
    Vageli, D.
    Sourvinos, G.
    Ioannou, M.
    Koukoulis, G. K.
    Spandidos, D. A.
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2007, 22 (04): : 239 - 244
  • [30] Incidence of high risk HPV (HR-HPV) and cervical dysplasia in Nigeria
    Umenyl, Chito
    Schnatz, Peter
    Waszczak, Wendy
    Mandavilli, Srinivas R.
    [J]. CANCER CYTOPATHOLOGY, 2007, 111 (05): : 378 - 378
12345